Fortress Biotech (FBIO) Income towards Parent Company (2010 - 2026)

Fortress Biotech's Income towards Parent Company history runs 16 years deep, the most recent figure standing at -$6.0 million for Q4 2025.

• In Q4 2025, Income towards Parent Company rose 77.15% year-over-year to -$6.0 million; the TTM figure through Dec 2025 stood at -$61.5 million (up 48.96% YoY), while the FY2025 annual figure was -$33.5 million, up 72.25% from the prior year.
• Income towards Parent Company for Q4 2025 stood at -$6.0 million, down from $8.8 million in the prior quarter.
• The five-year high for Income towards Parent Company was $8.8 million in Q3 2025, with the low at -$62.1 million in Q1 2023.
• The 5-year median for Income towards Parent Company is -$38.7 million (2024), against an average of -$37.3 million.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company slumped 150.16% in 2024, then surged 133.03% in 2025.
• Fortress Biotech's Income towards Parent Company stood at -$59.9 million in 2021, then rose by 4.03% to -$57.4 million in 2022, then jumped by 49.58% to -$29.0 million in 2023, then climbed by 9.14% to -$26.3 million in 2024, then surged by 77.15% to -$6.0 million in 2025.
• Business Quant data shows FBIO's Income towards Parent Company at -$6.0 million in Q4 2025, $8.8 million in Q3 2025, and -$39.1 million in Q2 2025.